Stock Markets Analysis & Opinion

We may be about to enter a new golden age of gold mining deals as explorers and producers seek to capitalize on higher metal prices and gain exposure to other key minerals, including copper, at a time...

The S&P 500 surged 1.3% Thursday after we got a few more pieces of data showing inflation continues falling. Sure, inflation’s retreat is slower than most hoped for or even expected, but...

Delta Airlines reported a mixed quarter but gave robust guidance. Record-free cash flow allowed accelerated debt reduction. Analysts are in the cockpit and are pointing this stock to higher...

S&P 500 EPS growth for Q1 2023 is set to come in at -6.8%, the lowest rate in nearly 3 years Themes from Q1 and for CY 2023: inflation, increasing interest rates, possibility of recession,...

Johnson & Johnson is a solid consumer staples stock. The company is expected to report earnings that are slightly lower than the same quarter in 2022, but full-year guidance is still expected to...

While the upcoming US recession is capturing the headlines, this downturn may look very different than previous ones. Our conversations with over 50 CEOs and CFOs over the past several weeks paint a...

The CPI report was good, but you shouldn't get bullish about it. Oil prices are on the rise and will accelerate inflation. The Fed may pause after the next hike, but more hikes are on the way in...

The Complete Trader, as displayed below, is one of my favorite go-to’s for trading ideas. The columns help determine the trade setup. For example, an "Inside Day" that is also in a bullish stock...

The S&P 500 finished Wednesday down 0.4% after the monthly inflation report dipped to 5%, the lowest reading in nearly two years. Stocks reflexively rallied on the news of falling inflation....

For readers, new and returning, allow me to refresh your memory. Since Mid-October last year, see here; we were starting to look for the possibility of a multi-month rally. Here’s what we found...

Moderna (NASDAQ:MRNA) shares closed lower on Tuesday after the vaccine maker said that its vaccine against seasonal flu did not achieve “early success” in the Phase 3 trial. Following...

Shares have been rallying hard since October’s low. Recent comments urge caution in the near-term. The longer-term opportunity remains strong however. A 90% rally since the middle of October...

Shares are up 50% since October and looking strong. Yesterday’s dip was the biggest in weeks. There are a ton of reasons to think this will soon be more than reversed. Shares of tech giant...

The S&P 500 finished Tuesday almost exactly where Monday’s session ended. The flat trade over the last week is proving both bulls and bears wrong. As I’ve been writing for a while,...